New Congressional Research Report on Cannabis Rescheduling Published

Key Takeaway

Congressional Research Service researchers released a new analysis noting that cannabis rescheduling to Schedule III would be a 'transitional' step requiring extensive follow-up reforms in banking, interstate commerce, and criminal justice. The report emphasized that rescheduling alone would not bring state-legal cannabis markets into full compliance with federal law, as Schedule III substances still require prescription-like protocols incompatible with adult-use retail models. The analysis is influential because congressional staff use CRS reports to shape policy proposals. For cannabis operators, the report validates industry arguments that rescheduling is necessary but insufficient, and that comprehensive federal legislation will still be needed to fully normalize state-legal markets.